Trump budget would cut $675B in healthcare spending by 2028

The fiscal year 2019 budget proposal from President Donald Trump’s administration would cut nearly $18 billion in funding to HHS, while relying on repealing the Affordable Care Act (ACA) and turning Medicaid into a state-administered block grant program to reduce healthcare spending by the federal government by $675 billion by 2028.

While the budget proposal contains many provisions Congress would have to enact—but likely won’t—the $1.4 trillion in proposed cuts to Medicaid (offset by the block grant spending) show where the administration’s priorities lie. As Vox explains, this budget would fundamentally change the nature of the program, capping spending based on a rate which is already below medical price growth.

It would also cut $266 billion in “wasteful spending” within Medicaid by cutting payments to providers. Smaller cuts would come from policy changes like increasing copayments for beneficiaries judged to have improperly visited an emergency room or denying benefits to people who can’t prove their immigration status.

Read more about the budget, including additional funding to tackle opioid abuse and changes to the Medicare prescription drug benefit, at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.